Scott Fidel
Stock Analyst at Stephens & Co.
(4.31)
# 429
Out of 4,734 analysts
177
Total ratings
69.72%
Success rate
8.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $14.58 | +16.60% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $62.25 | +17.27% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $509.76 | +32.42% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $13.82 | +124.31% | 4 | Nov 18, 2024 | |
| ADUS Addus HomeCare | Maintains: Overweight | $143 → $145 | $133.87 | +8.31% | 11 | Nov 6, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $283.99 | +44.37% | 12 | Nov 1, 2024 | |
| ENSG The Ensign Group | Maintains: Overweight | $163 → $167 | $136.79 | +22.08% | 9 | Oct 28, 2024 | |
| GRDN Guardian Pharmacy Services | Initiates: Overweight | $21 | $20.69 | +1.50% | 1 | Oct 22, 2024 | |
| HUM Humana | Reiterates: Equal-Weight | $250 | $282.63 | -11.55% | 7 | Oct 9, 2024 | |
| PNTG The Pennant Group | Reiterates: Overweight | $40 | $27.46 | +45.67% | 17 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $24 | $14.10 | +70.21% | 2 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $385.29 | +59.62% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $94.74 | +10.83% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $286.21 | +11.81% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $200 | $184.80 | +8.23% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $130.86 | -6.77% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $43.78 | +110.14% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $310.45 | -9.81% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $6.49 | +1,363.79% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $103 | $91.91 | +12.07% | 12 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $4.65 | -67.74% | 3 | Nov 11, 2022 |
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $14.58
Upside: +16.60%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $62.25
Upside: +17.27%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $509.76
Upside: +32.42%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $13.82
Upside: +124.31%
Addus HomeCare
Nov 6, 2024
Maintains: Overweight
Price Target: $143 → $145
Current: $133.87
Upside: +8.31%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $283.99
Upside: +44.37%
The Ensign Group
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $136.79
Upside: +22.08%
Guardian Pharmacy Services
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $20.69
Upside: +1.50%
Humana
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $282.63
Upside: -11.55%
The Pennant Group
Oct 9, 2024
Reiterates: Overweight
Price Target: $40
Current: $27.46
Upside: +45.67%
Sep 19, 2024
Reiterates: Overweight
Price Target: $24
Current: $14.10
Upside: +70.21%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $385.29
Upside: +59.62%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $94.74
Upside: +10.83%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $286.21
Upside: +11.81%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $200
Current: $184.80
Upside: +8.23%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $130.86
Upside: -6.77%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $43.78
Upside: +110.14%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $310.45
Upside: -9.81%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $6.49
Upside: +1,363.79%
May 4, 2023
Reiterates: Equal-Weight
Price Target: $103
Current: $91.91
Upside: +12.07%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $4.65
Upside: -67.74%